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Classifying Nuclei Shape Heterogeneity in Breast Tumors with Skeletons
Brian Falkenstein, M.S.
University of Pittsburgh, 2020
In this study, we demonstrate the efficacy of medial axis derived scoring statistics for
differentiating tumor and non-tumor nuclei in malignant breast tumor histopathology images.
Characterizing nuclei shape is a crucial part of diagnosing breast tumors, and these scoring
metrics may be integrated into algorithms which aggregate nuclei information across a region
to label whole breast lesions. Nuclei and region scoring algorithms such as the one presented
here can aid pathologists in the diagnosis of breast tumors.
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1.0 Introduction
Recent advancements in whole slide imaging technology have paved the way for what
has been termed Digital Pathology, the digitization of pathology data. Once a biopsy sample
has been processed, it can then be scanned into a digital format for viewing by the pathol-
ogist. This allows for viewing by the pathologist at any time, while not effecting diagnostic
accuracy [Sha+16]. Additional benefits of Digital Pathology include the ability to store large
amounts of cases for teaching and research purposes, as well as facilitating telepathology,
allowing multiple pathologists to view cases simultaneously and remotely. However, what
we are most interested in is how the digitization of pathology data allows for the use of com-
putational algorithms to analyze the data and provide useful information to the pathologist.
Slices of the extracted tissue sample are scanned into WSI’s, or whole slide images.
These images are far too large and high resolution (around 5 gigapixels) to perform most
analytical computation on, so ROI’s, or regions of interest, may be extracted via a plethora
of methods[Kot+13]. These smaller sub-regions of the whole slide (usually around 1M pixels)
are likely to contain information useful to the diagnosis, while ignoring large parts of the
image which are not useful (such as white space). Most useful computational analysis is
done on the region level. With these manageable ROI’s, we can employ a variety of machine
learning and computer vision techniques to guide pathologists in the decision making process.
This study focuses on breast tumor analysis in particular for several reasons. Breast
cancer is the second most common form of cancer found in women in the US, with an esti-
mated 12% of women developing invasive breast cancer over the course of their life[Bre20].
Annually, roughly 1.6 million breast biopsies are conducted, with around 25% of them show-
ing malignancy[Elm+15]. The remaining cases may be classified along a spectrum of labels,
from fully benign up to a very high risk of becoming malignant in the future. The differences
in appearance between these classes of pre-malginant tumors can be incredibly subtle, which
is reflected in the high rates of discordant diagnoses among pathologists for those high-risk
cases[Elm+15]. Further, accurate diagnosis of these lesions is crucial in providing optimal
treatment, and early detection and treatment reduces risk of future malignancy[Har+15;
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CLW20; Kad+18].
This begs the question: what are pathologists looking for when they are making these
diagnoses? Distinguishing between invasive and non-invasive cancer is relatively easy com-
pared to grading high-risk lesions, with discordance rates among invasive cases being as low
as 4%[Elm+15] (compared to 52% for high risk benign lesions). However, differentiating
between a benign lesion and a low or high risk lesions requires analysis of subtle structural
changes in the breast tissue. Complex, high-level structural changes occur in the tumor
region as it progresses along the spectrum from benign to malignant[Hal19]. High-risk le-
sions often show breast ducts being crowded with nuclei in rigid patterns around the lumen
(interior opening of the duct). Even the smallest structures present in the tissue, the cell
nuclei, demonstrate a change in shape across the disease spectrum.
Higher risk lesions, like FEA (flat epithelial atypia) have rounder epithelial nuclei than
lower risk lesions like CCC (columnar cell change)[Yam+16]. ADH (atypical ductal hyper-
plasia) is one of the highest risk tumors. Epithelial nuclei in ADH tumors are typically
completely rounded[PR92]. To get a full picture of the tumor environment in order to make
an accurate prediction, one must consider not only the distribution of structures across the
image (how dense the nuclei are crowded and in what pattern), but also the shape of the
structures themselves, in particular the nuclei. That is the focus of this study, to find an
accurate and robust way of characterizing the shape of epithelial nuclei in breast tumors.
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2.0 Methods
2.1 Data
Due to the lack of annotated nuclei datasets for high-risk benign lesions, the study is con-
ducted on a dataset of labeled tumor and non-tumor nuclei, particularlyBreCaHAD[Aks+19].
It consists of 162 breast lesion images, all of which show varying degrees of malignancy. Each
nuclei in the images is labeled by a point which is its centroid in the image, and one of the
following class labels: mitosis, apoptosis, tumor nuclei, non-tumor nuclei, tubule, and non-
tubule. For our purposes, we were just interested in differentiating the tumor and non-tumor
nuclei. Theoretically, if we can design a framework to differentiate tumor and non-tumor nu-
clei in malignant cases based on shape, the same framework should be successful at analyzing
high-risk benign tumor nuclei, the more challenging task.
Some issues arise with the dataset. Most glaringly is the fact that all of the cases
are malignant. Ideally, we would be studying tumors across a wide distribution of disease
levels, including benign and high-risk benign. Similarly, although we know the cases are
malignant, there is no fine-grained label for each image. That is, we do not know the grade
of the malignancy in the images, and it can vary across the samples. The fact that all tissue
samples are malignant naturally leads to a dramatic class imbalance in the data, with almost
92% of nuclei labeled as ’tumor’. Additionally, the ground truth labels (centroid and class
label) are not enough for our purposes, so further processing must be done before testing
(segmentation, feature extraction).
2.2 Data Processing
If we wish to analyze the shape of the nuclei present in the biopsy images, we need
some definition of the boundaries of the nuclei. Ideally, this would come with the dataset,
and be a ground truth value. However, in our case, we are only given centroid locations of
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the nuclei, and thus must produce our own segmentation of the nuclei.
Many methods exist for segmenting nuclei in histopatholgy images, however the best
results can be gained from using deep learning techniques. Clearly, if our interest is studying
the shape of the nuclei in the images, we would desire the best possible segmentation so that
our shape representation of the nuclei is as close to reality as possible. For this study, I used
the segmentation algorithm proposed by Chen et al.[Che+19], which is a fully convolutional
network based off of U-Net[RFB15]. It works similarly to how a standard fully convultional
network does for semantic segmentation, just with some additional smoothing applied after
the upsampling.
Once the segmentation was computed, the labeled centroids could be matched to their
corresponding nuclei boundary by determining which (masked) boundary the centroid fell
within. The labels in the dataset could then be associated with a nuclei boundary. Using this
segmentation scheme, 80.18% of the ground truth nuclei in the dataset were found (18149
nuclei). Of these, 92% were positive (16689). Crops of size (81, 81) centered at each nuclei
were taken from the original images, and used as the training and testing data.
To account for the class imbalance, training and testing sets were obtained by randomly
sampling with replacement from the over-represented class (tumor) until there was an equal
number of samples for both classes. Without this step, the model would tend to demonstrate
very low specificity (high rate of false positives), while still maintaining a low loss. There
were 1460 negative (non-tumor) nuclei after segmentation, so the same number of positive
nuclei were randomly selected from the initial set of 16689. This is not ideal, as many
negative samples are thrown out, however it is preferable to an overfitted model.
2.3 Baselines
In order to show the efficacy of the proposed method for capturing nuclei shape, the
tests will be conducted on features with no information of texture or color in the nuclei. For
this reason, I will be testing my method against another method which does not incorporate
texture, but has shown to be successful. Yamamoto et al.[Yam+17] obtained an accuracy
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of 85% using only a small number of hand-picked morphological features and an SVM. I
was able to replicate their accuracy results on the balanced test set using the following
set of features: area, eccentricity, extend, major axis, minor axis, convex area, circularity,
equivalent diameter, filled area, perimeter, and solidity. Note again how none of these
features incorporate any color or texture information.
However, color and texture features have also been used with success[Wan+16]. For
this reason, I will also be comparing the proposed shape-based method to a method which
includes color, particularly a small CNN. The CNN used was AlexNet[KSH12], pre-trained
on ImageNet, and the features were extracted from the last fully-connected layer (D=1000).
The CNN was tested both on the full color crops, as well as the 3-channel skeleton score
image (see below).
2.4 Medial Axis Transform Scoring
Using the medial axis transform (MAT) for the nuclei shape analysis is the novel idea
proposed in this study. The MAT is a skeletonization algorithm wherein a closed binary
shape is reduced down to a 1 pixel wide branching structure wholly contained within the
original shape. This may be conceptualized as a thinning process, where the border of the
shape becomes thinner, or erodes, until opposite sides of the shape come together, defining
the skeleton. The skeleton points are center points of maximally inscribed discs, circles with
more than one point on their surface tangent to the shape boundary. This property makes
the MAT skeletonization an interesting candidate for deriving a shape descriptor.
However, the skeleton itself does not contain enough information on its own, but can be
used further to derive several scoring statistics. Rezanejad et al.[Rez+19] derive 3 scores from
the MAT: ribbon, taper, and separation. They also show that these scores can be succesfully
used by a CNN to perform scene classification from line images (no color or texture).
Let p be a point on the skeleton, R(p) be the radius function for that point (distance from
skeleton point to boundary), and [α, β] be a range of points of size k. Finally, let p ∈ [α, β].
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Then the three score metrics are defined as follows:
Sribbon(p) = R
′(p)
Staper(p) = R
′′(p)
Sseparation(p) = 1−
∫ β
α
1
R(p)
dp/k
Because pixels are discrete, and thus so are the intervals we are integrating and deriving
over, we must use numerical gradients. A small value of k was used, as the nuclei are fairly
small (roughly 100 pixel perimeter), and the scoring metrics are designed to capture local
symmetry. For all of the tests, I used a value of k=8.
The ribbon score captures the degree of parallelity of the surrounding contours, and
increases as they become more parallel. Taper score is designed to increase as contours
resemble the shape of a funnel or railroad tracks, but also has a high value for parallel
contours. Separation captures the degree of separation between the contours, and increases
with distance.
These algorithms define 3 scores for each skeleton point. Thus, it could be treated as
a 3-channel color image, where all non-skeletal pixels have a value of 0 and skeleton points
are described with 3 scores. This can then be fed through a CNN to extract features from,
which was done.
Another method of extracting a 1 dimensional feature from the skeleton scores is just to
extract summery information. This involved taking several averaging statistics of the scores,
while also considering structural information of the skeleton itself. The following features
were extracted from the scores: min, max, average and standard deviation of each score
(ribbon, taper, separation) across the skeleton. The following additional skeleton structural
features were extracted: number of branches, average and max branch length, and bend
(angle between line connecting furthest 2 skeleton points and major axis). Note that all of
these features are independent of any baseline features mentioned, and thus could be used
as supplemental information to aid in classification.
Another interesting method for extracting a feature from the skeleton data would be
to define the skeleton as a graph, with node features being the 3 scores, and apply graph
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convolutions or graph kernels to do the classification. Deep learning on graph structured
data has shown promise in recent years and could prove useful in this task. However, the
graph analysis is outside of the scope of this study currently.
The skeletonization code was adapted from [Rez19; Sid+02; DDS03; RS13], and the
scoring code was written by me.
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3.0 Results
Results can be seen in table 1. Classification for all tests was done using a linear
SVM with RBF kernel. Recall that there is equal class representation, so a random algorithm
would achieve an accuracy of roughly 0.5. Scores were averaged over 20 runs.
Table 1: BreCaHAD Classification Results
Method Accuracy Sensitivity Specificity
Morphological features 0.846 +/- 0.001 0.831 +/- 0.001 0.861 +/- 0.001
CNN on full color crop 0.632 +/- 0.001 0.477 +/- 0.001 0.798 +/- 0.001
CNN on 3-channel skeleton image 0.654 +/- 0.002 0.623 +/- 0.001 0.687 +/- 0.001
MAT Skeleton features 0.850 +/- 0.004 0.844 +/- 0.004 0.852 +/- 0.003
Although the proposed method achieved the highest accuracy, we reject the null hy-
pothesis that the distributions of accuracies for the skeleton features and the morphological
features come from different distributions at significance level 5%. So, it is an improvement
over the baseline morphological features, but not by much. Additionally, the MAT skele-
ton feature achieved the highest sensitivity of the methods testing. Sensitivity is especially
important in a medical setting, where a false negative (missed disease diagnosis) is much
more costly than a false positive (where a patient may receive unnecessary further testing
or treatment). This also highlights the failure of the color CNN feature, where its passable
accuracy score was achieved by outputting mostly negative labels, resulting in many false
negatives. It also demonstrates that the 3-channel skeleton image CNN feature was actually
significantly better than the CNN on the full color image, as is seen in the difference in
sensitivity.
Scores could likely be improved for both the morphological and skeleton features by tak-
ing several steps. First, color features could be incorporated into the skeleton and morpho-
logical features. These could be extracted from a CNN, or just be basic statistical measures
such as in [Wan+16]. Additionally, a better classifier could have been used, such as a simple
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multi-layer neural network. However, with these results we have shown the efficacy of the
MAT skeleton feature as a means of distinguishing nuclei shapes.
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4.0 Conclusions
Overall, the purpose of the study was not to achieve the best classification metrics and
beat out all other state of the art models, but rather to define a useful shape descriptor that
accurately captures the change of shape of the nucleus. In that regards, it was a success.
The MAT skeleton feature showed improvement over the baseline morphological features.
Additionally, features extracted with a CNN on the weighted skeleton image performed
better than similar features extracted from the full color image. The MAT skeleton scoring
algorithm outlined in this paper is thus a useful shape descriptor in regards to tracking nuclei
shape heterogeneity in breast tumors.
Although here applied to distinguishing tumor and non-tumor nuclei in malignant breast
tumors, the MAT scores may be robust enough to tackle harder challenges, such as the
classification of high-risk tumors, or be applied to other modalities and cancers, such as
prostate cancer (which also uses stained slide images for diagnosis). Further work will focus
on applying this technique to more challenging tasks and datasets.
We can also apply the nucleus scoring algorithm, where each nuclei receives a set of
features, to classify a whole region by considering all the nuclei in the region. One way
to do this could be to just take a majority vote. If the majority of nuclei in the region
are cancerous, then predict the image as cancerous. Another method could be normalized
mean statistics being taken over the graph to return a 1 dimensional vector. These are naive
approaches, but they highlights how the MAT scores may extend beyond nuclei classification.
A more interesting way to combine the nuclei features across the image could be to define
a graph over the image, where the nodes in the graph are the nuclei, and each node inherits
the features describing the nuclei. This would maintain the structure and distribution of
nuclei in the original image, while allowing for various graph learning methods to be applied,
which can consider both the individual nuclei features, as well as the overall structure of the
tumor environment. This is a topic for further study.
I would also like to highlight the importance of model interpretability in medical studies
such as this one. Many deep learning models exist which obtain impressive classification
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results in this domain, such as in [Alo+18] where they achieve almost 98% accuracy on the
BreakHis dataset (benign vs. malignant tumors). However, one thing missing from deep
learning models is the ability to easily interpret results. Methods exist for probing deep nets
to try to obtain some idea of what its doing, but a deep net will never be as interpretable by
a human as a simpler model, such as an SVM. This is especially important when considering
who will be using the software, primarily pathologists, who are not experts in data science.
Using hand-picked features which can be mapped to real world descriptions (such as a nucleus
being rounded) and simpler decision models leads to better potential interpretability and
more trust in the model. Further work could include adding interpretability into the proposed
feature extraction framework. If our aim is to improve the field of pathology by providing
pathologists with tools that will aid them in their diagnostic process, a crucial step is gaining
the trust of pathologists, and that can be accomplished through model interpretability.
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